Tranquility Partners’s Bristol-Myers Squibb BMY Stock Holding History

Tranquility Partners’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-3,241	Closed	-$207K	–	212
2023 Q2	$207K	Buy	3,241 +22	+0.7%	+$1.48K	0.09%	210
2023 Q1	$223K	Sell	3,219 -6	-0.2%	-$423	0.11%	192
2022 Q4	$232K	Sell	3,225 -300	-9%	-$22.6K	0.12%	181
2022 Q3	$251K	Hold	3,525	–	–	0.14%	156
2022 Q2	$271K	Sell	3,525 -300	-8%	-$22.8K	0.14%	161
2022 Q1	$279K	Buy	3,825 +399	+12%	+$26.8K	0.13%	167
2021 Q4	$214K	Sell	3,426 -103	-3%	-$6.04K	0.1%	201
2021 Q3	$209K	Buy	+3,529	New	+$232K	0.11%	204

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Tranquility Partners's BMY Position: Q3 2023 in Review

Tranquility Partners sold out of Bristol-Myers Squibb (BMY) in Q3 2023, closing a stake of 3,241 shares — an estimated $207K sold.

Tranquility Partners first reported a position in BMY in Q3 2021 and held it in 8 quarters. The position peaked at $279K in Q1 2022. 2,387 funds tracked by Wall St. Rank hold BMY as of Q3 2023.

Tranquility Partners reported no remaining Bristol-Myers Squibb position as of Q3 2023 after selling out during the quarter.
Tranquility Partners sold 3,241 Bristol-Myers Squibb shares in Q3 2023, an estimated $207K.
Tranquility Partners first reported a position in Bristol-Myers Squibb in Q3 2021 and held it in 8 quarters.
Tranquility Partners's Bristol-Myers Squibb position peaked at $279K in Q1 2022.
2,387 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2023.

Based on Tranquility Partners's 13F filing for Q3 2023, filed 31 Oct 2023.